• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Healthcare Services Group, Inc. Reports Q1 2023 Results

    4/26/23 7:00:00 AM ET
    $HCSG
    Hospital/Nursing Management
    Health Care
    Get the next $HCSG alert in real time by email

    Continues Positive Business Momentum, Adjusted EBITDA up 18%

    Healthcare Services Group, Inc. (NASDAQ:HCSG) (the "Company") reported for the three months ended March 31, 2023 revenue of $417.2 million, GAAP net income of $12.7 million, or $0.17 per basic and diluted common share, and adjusted EBITDA of $27.5 million.

    Q1 Results

    • Revenue for the quarter was reported at $417.2 million, with housekeeping & laundry and dining & nutrition segment revenues of $193.5 million and $223.7 million, respectively.
    • Housekeeping & laundry and dining & nutrition segment margins were 10.4% and 6.6%, respectively.
    • Direct cost of services was reported at $361.0 million, or 86.5%. Direct cost included a $6.9 million increase in CECL AR reserves.
    • Selling, general and administrative ("SG&A") was reported at $40.0 million; after adjusting for the $1.5 million increase in deferred compensation, actual SG&A was $38.5 million, or 9.2%.
    • The effective tax rate was 27.8%, which included discrete items specific to Q1. The Company expects a 2023 tax rate of 24% to 26%.
    • Adjusted EBITDA was $27.5 million, an 18% increase over the prior year's corresponding quarter.
    • Cash flow used in operations for the quarter was $16.3 million and was impacted by a $21.2 million decrease in accrued payroll and a $20.6 million increase in accounts receivable related to the timing of cash collections. DSO for the quarter was 76 days.

    Ted Wahl, Chief Executive Officer, stated, "We delivered strong operating results and service execution during the quarter, as our relentless focus on customer experience, systems adherence and regulatory compliance led to high quality and consistent outcomes for our client-partners. We successfully managed cost of services in line with our target of 86% and showed marked improvement in Q1 cash collections year over year in what has historically been our most challenging cash collections quarter. We also successfully exited the final tranche of facilities related to the 2022 contract modification initiative, providing a solid foundation for us to grow in the future."

    Mr. Wahl concluded, "Industry fundamentals continue to improve, and a stabilizing labor market and stronger reimbursement environment, especially at the state level, contributed to what has been a gradual occupancy recovery. Looking ahead, we are focused on executing on our strategic priorities to drive growth, and we remain confident in our ability to deliver long-term value to our shareholders."

    Conference Call and Upcoming Events

    The Company will host a conference call on Wednesday, April 26, 2023, at 8:30 a.m. Eastern Time to discuss its results for the three months ended March 31, 2023. The call may be accessed via phone at 1 (888) 330-3451, Conference ID: 4431380. The call will be simultaneously webcast under the "Events & Presentations" section of the Investor Relations page on the Company's website, www.hcsg.com. A replay of the webcast will also be available on the website for one year following the date of the earnings call.

    CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

    This release and any schedules incorporated by reference into it may contain forward-looking statements within the meaning of federal securities laws, which are not historical facts but rather are based on current expectations, estimates and projections about our business and industry, and our beliefs and assumptions. Words such as "believes," "anticipates," "plans," "expects," "estimates," "will," "goal," and similar expressions are intended to identify forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by us that any of our plans will be achieved. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Such forward-looking information is also subject to various risks and uncertainties. Such risks and uncertainties include, but are not limited to, risks arising from our providing services to the healthcare industry and primarily providers of long-term care; the impact of and future effects of the COVID-19 pandemic or other potential pandemics; having a significant portion of our consolidated revenues contributed by one customer during the three months ended March 31, 2023; credit and collection risks associated with the healthcare industry; the impact of bank failures; our claims experience related to workers' compensation and general liability insurance (including any litigation claims, enforcement actions, regulatory actions and investigations arising from personal injury and loss of life related to COVID-19); the effects of changes in, or interpretations of laws and regulations governing the healthcare industry, our workforce and services provided, including state and local regulations pertaining to the taxability of our services and other labor-related matters such as minimum wage increases; the Company's expectations with respect to selling, general, and administrative expense; and the risk factors described in Part I of our Form 10-K for the fiscal year ended December 31, 2022 under "Government Regulation of Customers," "Service Agreements and Collections," and "Competition" and under Item 1A. "Risk Factors" in such Form 10-K.

    These factors, in addition to delays in payments from customers and/or customers in bankruptcy, have resulted in, and could continue to result in, significant additional bad debts in the near future. Additionally, our operating results would be adversely affected by continued inflation particularly if increases in the costs of labor and labor-related costs, materials, supplies and equipment used in performing services (including the impact of potential tariffs and COVID-19) cannot be passed on to our customers.

    In addition, we believe that to improve our financial performance we must continue to obtain service agreements with new customers, retain and provide new services to existing customers, achieve modest price increases on current service agreements with existing customers and/or maintain internal cost reduction strategies at our various operational levels. Furthermore, we believe that our ability to sustain the internal development of managerial personnel is an important factor impacting future operating results and the successful execution of our projected growth strategies. There can be no assurance that we will be successful in that regard.

    USE OF NON-GAAP FINANCIAL INFORMATION

    To supplement HCSG's consolidated financial information, which are prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP"), the Company believes that certain non-GAAP financial measures are useful in evaluating operating performance and comparing such performance to other companies.

    The Company is presenting earnings before interest, taxes, depreciation and amortization ("EBITDA"), and excluding items impacting comparability ("Adjusted EBITDA"). We cannot provide a reconciliation of forward-looking EBITDA and Adjusted EBITDA margin measures to GAAP due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation. The presentation of non-GAAP financial measures is not meant to be considered in isolation or as a substitute for financial statements prepared in accordance with GAAP.

    HEALTHCARE SERVICES GROUP, INC.

    CONSOLIDATED STATEMENTS OF INCOME

    (Unaudited)

    (in thousands, except per share data)

     

     

     

    For the Three Months Ended

     

     

    March 31,

     

     

    2023

     

    2022

     

    Revenues

     

    $

    417,230

     

    $

    426,811

     

    Operating costs and expenses:

     

     

     

     

    Costs of services provided

     

     

    360,978

     

     

    373,262

     

    Selling, general and administrative

     

     

    40,047

     

     

    35,736

     

    Income from operations

     

     

    16,205

     

     

    17,813

     

    Other income (expense), net

     

     

    1,351

     

     

    (2,032

    )

    Income before income taxes

     

     

    17,556

     

     

    15,781

     

     

     

     

     

     

    Income tax provision

     

     

    4,872

     

     

    4,452

     

    Net income

     

    $

    12,684

     

    $

    11,329

     

     

     

     

     

     

    Basic earnings per common share

     

    $

    0.17

     

    $

    0.15

     

     

     

     

     

     

    Diluted earnings per common share

     

    $

    0.17

     

    $

    0.15

     

     

     

     

     

     

    Basic weighted average number of common shares outstanding

     

     

    74,497

     

     

    74,326

     

     

     

     

     

     

    Diluted weighted average number of common shares outstanding

     

     

    74,518

     

     

    74,333

     

    HEALTHCARE SERVICES GROUP, INC.

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (Unaudited)

    (in thousands)

     

     

    March 31, 2023

     

    December 31, 2022

    Cash and cash equivalents

    $

    16,153

     

    $

    26,279

    Marketable securities, at fair value

     

    95,985

     

     

    95,200

    Accounts and notes receivable, net

     

    350,784

     

     

    336,777

    Other current assets

     

    47,165

     

     

    50,376

    Total current assets

     

    510,087

     

     

    508,632

     

     

     

     

    Property and equipment, net

     

    23,400

     

     

    22,975

    Notes receivable — long-term

     

    32,327

     

     

    32,609

    Goodwill

     

    75,529

     

     

    75,529

    Other intangible assets, net

     

    14,743

     

     

    15,946

    Deferred compensation funding

     

    34,312

     

     

    33,493

    Other assets

     

    28,735

     

     

    29,150

    Total assets

    $

    719,133

     

    $

    718,334

     

     

     

     

    Accrued insurance claims — current

    $

    23,974

     

    $

    23,166

    Other current liabilities

     

    138,190

     

     

    155,453

    Total current liabilities

     

    162,164

     

     

    178,619

     

     

     

     

    Accrued insurance claims — long-term

     

    67,100

     

     

    65,541

    Deferred compensation liability — long-term

     

    34,263

     

     

    33,764

    Lease liability — long-term

     

    8,586

     

     

    8,097

    Other long term liabilities

     

    6,448

     

     

    6,141

    Stockholders' equity

     

    440,572

     

     

    426,172

    Total liabilities and stockholders' equity

    $

    719,133

     

    $

    718,334

    HEALTHCARE SERVICES GROUP, INC.

    RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES

    (Unaudited)

    (in thousands)

     

     

     

    For the three months ended

    March 31,

     

     

     

     

    2023

     

    2022

     

    Reconciliation of Net Income to EBITDA and Adjusted EBITDA

     

     

     

     

    Net income

     

    $

    12,684

     

    $

    11,329

     

    Income tax provision

     

     

    4,872

     

     

    4,452

     

    Interest, net

     

     

    102

     

     

    (417

    )

    Depreciation & amortization

     

     

    3,720

     

     

    4,147

     

    EBITDA

     

    $

    21,378

     

    $

    19,511

     

    Share-based compensation

     

     

    2,058

     

     

    2,396

     

    Gain/loss on deferred compensation, net

     

     

    44

     

     

    289

     

    Bad debt expense adjustments(1)

     

     

    4,035

     

     

    1,108

     

    Adjusted EBITDA

     

    $

    27,515

     

    $

    23,304

     

    (1) The bad debt expense adjustment reflects the difference between GAAP bad debt expense (CECL) and historical write-offs as a percentage of revenues, both of which are based on the same seven year look-back period.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230426005308/en/

    Get the next $HCSG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HCSG

    DatePrice TargetRatingAnalyst
    2/20/2026Mkt Perform → Outperform
    William Blair
    11/13/2025$20.00Market Perform
    BMO Capital Markets
    7/29/2025$16.00Neutral → Outperform
    Macquarie
    4/24/2025$15.00Neutral → Buy
    UBS
    12/16/2024Neutral
    Macquarie
    3/24/2023$8.50 → $14.00Underperform → Hold
    Jefferies
    2/17/2023$14.00 → $17.00Sector Perform → Outperform
    RBC Capital Mkts
    10/20/2022$18.00Hold → Buy
    The Benchmark Company
    More analyst ratings

    $HCSG
    SEC Filings

    View All

    SEC Form 10-K filed by Healthcare Services Group Inc.

    10-K - HEALTHCARE SERVICES GROUP INC (0000731012) (Filer)

    2/13/26 4:27:08 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    Healthcare Services Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - HEALTHCARE SERVICES GROUP INC (0000731012) (Filer)

    2/11/26 7:01:50 AM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    SEC Form 10-Q filed by Healthcare Services Group Inc.

    10-Q - HEALTHCARE SERVICES GROUP INC (0000731012) (Filer)

    10/24/25 4:02:57 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    $HCSG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP & Chief Revenue Officer Orr Patrick J sold $915,835 worth of shares (44,615 units at $20.53), closing all direct ownership in the company (SEC Form 4)

    4 - HEALTHCARE SERVICES GROUP INC (0000731012) (Issuer)

    2/20/26 4:58:25 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    EVP & Chief Revenue Officer Orr Patrick J exercised 45,500 shares at a strike of $14.62 and sold $934,570 worth of shares (45,500 units at $20.54) (SEC Form 4)

    4 - HEALTHCARE SERVICES GROUP INC (0000731012) (Issuer)

    2/19/26 8:36:25 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    EVP & Chief Admin. Officer Shea John Christopher sold $1,109,189 worth of shares (54,357 units at $20.41) and exercised 38,857 shares at a strike of $17.05, decreasing direct ownership by 35% to 29,292 units (SEC Form 4)

    4 - HEALTHCARE SERVICES GROUP INC (0000731012) (Issuer)

    2/19/26 8:34:36 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    $HCSG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $HCSG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Healthcare Services Group Reports Full Year and Fourth Quarter Results

    Exceeds 2025 Expectations Announces New Share Repurchase Program Provides 2026 Growth Outlook Revenue: $1.84 billion for the year (+7.1%) and $466.7 million for the quarter (+6.6%). Net income and EPS: $59.1 million or $0.81 for the year and $31.2 million or $0.44 for the quarter. Cash flow from operations: $145.0 million for the year and $17.4 million for the quarter. Excluding change in payroll accrual, $164.1 million for the year and $36.4 million for the quarter. Share repurchase: Completes $50.0 million buyback and authorizes new $75.0 million, 12-month program. 2026 outlook: Expects mid-single-digit revenue growth. Healthcare Services Group, Inc. (NASDAQ:HCSG) to

    2/11/26 7:00:00 AM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    HCSG Reports Third Quarter Results

    Exceeds Revenue, Earnings and Cash Flow Expectations  Revenue of $464.3 million, an 8.5% increase over the prior year. Net income and diluted EPS of $43.0 million and $0.59; includes $0.361 benefit primarily related to the Employee Retention Credit (ERC). Cash flow from operations and cash flow from operations, excluding the change in payroll accrual, of $71.3 million and $87.1 million; includes $31.8 million benefit related to the ERC. Share repurchases of $27.3 million under previously announced $50.0 million, 12-month share repurchase plan. Healthcare Services Group, Inc. (NASDAQ:HCSG) today reported results for the three months ended September 30, 2025. Ted Wahl, Chief

    10/22/25 7:00:00 AM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    HCSG Reports Second Quarter Results

    Exceeds Growth Expectations Raises 2025 Cash Flow Forecast Announces $50.0MM Share Repurchase Plan Revenue of $458.5 million, an increase of 7.6% over the prior year. Net income and diluted EPS of ($32.4) million and ($0.44); includes $0.65 non-cash charge related to previously announced Genesis HealthCare restructuring. Cash flow from operations of $28.8 million; cash flow from operations (excluding the change in payroll accrual) of $8.5 million, an increase of $10.9 million over the prior year. Reiterates 2025 mid-single digit growth expectations. Raises 2025 cash flow from operations forecast (excluding the change in payroll accrual) from $60.0 to $75.0 million to $70.0 to

    7/23/25 7:00:00 AM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    Healthcare Services Group upgraded by William Blair

    William Blair upgraded Healthcare Services Group from Mkt Perform to Outperform

    2/20/26 8:19:55 AM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    BMO Capital Markets initiated coverage on Healthcare Services Group with a new price target

    BMO Capital Markets initiated coverage of Healthcare Services Group with a rating of Market Perform and set a new price target of $20.00

    11/13/25 9:13:33 AM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    Healthcare Services Group upgraded by Macquarie with a new price target

    Macquarie upgraded Healthcare Services Group from Neutral to Outperform and set a new price target of $16.00

    7/29/25 10:30:39 AM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    $HCSG
    Financials

    Live finance-specific insights

    View All

    Healthcare Services Group Reports Full Year and Fourth Quarter Results

    Exceeds 2025 Expectations Announces New Share Repurchase Program Provides 2026 Growth Outlook Revenue: $1.84 billion for the year (+7.1%) and $466.7 million for the quarter (+6.6%). Net income and EPS: $59.1 million or $0.81 for the year and $31.2 million or $0.44 for the quarter. Cash flow from operations: $145.0 million for the year and $17.4 million for the quarter. Excluding change in payroll accrual, $164.1 million for the year and $36.4 million for the quarter. Share repurchase: Completes $50.0 million buyback and authorizes new $75.0 million, 12-month program. 2026 outlook: Expects mid-single-digit revenue growth. Healthcare Services Group, Inc. (NASDAQ:HCSG) to

    2/11/26 7:00:00 AM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    HCSG Reports Third Quarter Results

    Exceeds Revenue, Earnings and Cash Flow Expectations  Revenue of $464.3 million, an 8.5% increase over the prior year. Net income and diluted EPS of $43.0 million and $0.59; includes $0.361 benefit primarily related to the Employee Retention Credit (ERC). Cash flow from operations and cash flow from operations, excluding the change in payroll accrual, of $71.3 million and $87.1 million; includes $31.8 million benefit related to the ERC. Share repurchases of $27.3 million under previously announced $50.0 million, 12-month share repurchase plan. Healthcare Services Group, Inc. (NASDAQ:HCSG) today reported results for the three months ended September 30, 2025. Ted Wahl, Chief

    10/22/25 7:00:00 AM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    HCSG Reports Second Quarter Results

    Exceeds Growth Expectations Raises 2025 Cash Flow Forecast Announces $50.0MM Share Repurchase Plan Revenue of $458.5 million, an increase of 7.6% over the prior year. Net income and diluted EPS of ($32.4) million and ($0.44); includes $0.65 non-cash charge related to previously announced Genesis HealthCare restructuring. Cash flow from operations of $28.8 million; cash flow from operations (excluding the change in payroll accrual) of $8.5 million, an increase of $10.9 million over the prior year. Reiterates 2025 mid-single digit growth expectations. Raises 2025 cash flow from operations forecast (excluding the change in payroll accrual) from $60.0 to $75.0 million to $70.0 to

    7/23/25 7:00:00 AM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    $HCSG
    Leadership Updates

    Live Leadership Updates

    View All

    HCSG Announces Appointment of Chief Financial Officer

    Healthcare Services Group, Inc. (NASDAQ:HCSG) today announced the appointment of Vikas Singh as EVP & Chief Financial Officer, effective September 3, 2024. He will oversee HCSG's accounting and finance operations, and play a key role in corporate development, investor relations, and the success of its long-term growth strategy. Mr. Singh brings over two decades of diverse experience in finance, strategy and operations to the Company. Most recently, he served as Managing Director of Leveraged Finance & Capital Markets at Bank of America Securities. Prior to that he worked in the Financial Sponsors Group at Credit Suisse and in the Asia-Pacific Credit Card Group at Citibank. Mr. Singh began

    9/9/24 12:00:00 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    $HCSG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Healthcare Services Group Inc.

    SC 13G/A - HEALTHCARE SERVICES GROUP INC (0000731012) (Subject)

    11/13/24 5:15:34 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13G/A filed by Healthcare Services Group Inc.

    SC 13G/A - HEALTHCARE SERVICES GROUP INC (0000731012) (Subject)

    10/15/24 1:08:04 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G/A filed by Healthcare Services Group Inc. (Amendment)

    SC 13G/A - HEALTHCARE SERVICES GROUP INC (0000731012) (Subject)

    2/13/24 5:06:23 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care